Ganirelix acetate
- Level
- Commodity
- Parent
- 51181900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51181929This classification denotes a gonadotropin releasing hormone inhibitor with the molecular formula C80H113CLN18O13.2C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56U7906FQW. European Medicines Agency schedules ganirelix acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25637. The term ganirelix acetate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule ganirelix acetate under HS 29371900 and SITC 54154. Ganirelix acetate bears US NLM identifiers UMLS ID C0872894 and NCI Concept Code C61774. SMILES: As of Q4 2014, GANIRELIX ACETATE remains US FDA's Preferred Term for this commodity.
Same parent
Under 51181900 · 23Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.